Related references
Note: Only part of the references are listed.Targeting tumor-associated macrophages as an antitumor strategy
Nan Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
Mate Kiss et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Research trends in pharmacological modulation of tumor-associated macrophages
Neng Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
Naveen Sharma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
Robert W. Lentz et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Tumor microenvironment as a therapeutic target in cancer
Yi Xiao et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Chunxiao Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CD40 Agonist Antibodies in Cancer Immunotherapy
Robert H. Vonderheide
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
Zhipeng Liu et al.
CANCER LETTERS (2020)
Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
Dongbo Li et al.
CANCER SCIENCE (2020)
Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma
Amr Ahmed El-Arabey et al.
CELLULAR SIGNALLING (2020)
Pivotal Involvement of the CX3CL1-CX3CR1 Axis for the Recruitment of M2 Tumor-Associated Macrophages in Skin Carcinogenesis
Yuko Ishida et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy
Daniel Baumann et al.
NATURE COMMUNICATIONS (2020)
Deciphering human macrophage development at single-cell resolution
Zhilei Bian et al.
NATURE (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
The expanding landscape of inflammatory cells affecting cancer therapy
Ralph Weissleder et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome
Manish A. Shah et al.
CLINICAL CANCER RESEARCH (2020)
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
Kaiyue Wu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages
Alessio Menga et al.
EMBO MOLECULAR MEDICINE (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC
Xing Li et al.
EXPERIMENTAL CELL RESEARCH (2019)
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Chen Wei et al.
MOLECULAR CANCER (2019)
Therapeutic targeting of trained immunity
Willem J. M. Mulder et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Tumor-associated macrophages: role in cancer development and therapeutic implications
Arash Salmaninejad et al.
CELLULAR ONCOLOGY (2019)
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
Niannian Ji et al.
ONCOIMMUNOLOGY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma
Yu-Chen Ye et al.
CANCER RESEARCH (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
William D. Tap et al.
LANCET (2019)
Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-kappa B-CCL2 signaling in lung cancer
Lisha Zhou et al.
ONCOGENE (2019)
Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
Jason B. Muhitch et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression
Anders Etzerodt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Stefanie R. Mullins et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Function, Regulation and Biological Roles of PI3Kγ Variants
Bernd Nuernberg et al.
BIOMOLECULES (2019)
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban-Wojciuk et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma
Laura Carminati et al.
CARCINOGENESIS (2019)
M2b macrophage polarization and its roles in diseases
Le-xun Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production
Yuanyuan Tong et al.
EBIOMEDICINE (2019)
Macrophages at the crossroads of anticancer strategies
Nina Cortese et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells
Jing Li et al.
IMMUNITY (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients
Wei-jie Zhang et al.
JOURNAL OF SURGICAL RESEARCH (2018)
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition
Emanuele Giurisato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Jennifer L. Guerriero
TRENDS IN MOLECULAR MEDICINE (2018)
Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
Amit Kumar Singh et al.
NUTRIENTS (2018)
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
Takanori Kitamura et al.
FRONTIERS IN IMMUNOLOGY (2018)
Macrophages of distinct origins contribute to tumor development in the lung
Pierre-Louis Loyher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
Hui-Ming Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways
Shiri Klein et al.
CANCER RESEARCH (2018)
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A. Barkal et al.
NATURE IMMUNOLOGY (2018)
Non-angiogenic tumours and their influence on cancer biology
Tom Donnem et al.
NATURE REVIEWS CANCER (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
Daniela F. Quail et al.
CLINICAL CANCER RESEARCH (2017)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
Yu Zhu et al.
IMMUNITY (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies
Changbin Zhu et al.
NEURO-ONCOLOGY (2017)
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
D. Yan et al.
ONCOGENE (2017)
COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
Victor Prima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Sharareh Gholamin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis
Oezge Canli et al.
CANCER CELL (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors
Vinit Kumar et al.
CANCER CELL (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
LILRB receptor-mediated regulation of myeloid cell maturation and function
William van der Touw et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young-hee Lee et al.
CELL RESEARCH (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Trabectedin for the treatment of breast cancer
Maurizio D'Incalci et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy
Giuseppe Di Caro et al.
GUT (2016)
Macrophage polarization: the link between inflammation and related diseases
Samina Bashir et al.
INFLAMMATION RESEARCH (2016)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Tissue-Resident Macrophage Ontogeny and Homeostasis
Florent Ginhoux et al.
IMMUNITY (2016)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
The development and maintenance of resident macrophages
Elisa Gomez Perdiguero et al.
NATURE IMMUNOLOGY (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Heleen. H. Van Acker et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Polarized CD163+tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer
Jae-Young Park et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
Michael Zhang et al.
PLOS ONE (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Zhenyu Xiao et al.
CANCER LETTERS (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma
Bastian von Tresckow et al.
CLINICAL CANCER RESEARCH (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
W. D. Tap et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Macrophages and cancer: from mechanisms to therapeutic implications
Renato Ostuni et al.
TRENDS IN IMMUNOLOGY (2015)
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
Allison S. Harney et al.
CANCER DISCOVERY (2015)
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
Ling Lin et al.
ONCOTARGET (2015)
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
Stephen L. Shiao et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
Tetje C. van der Sluis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer
Simon Junankar et al.
CANCER DISCOVERY (2015)
CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma
Young Wha Koh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
A. Neil Barclay et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Eun-Jin Yeo et al.
CANCER RESEARCH (2014)
Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function
Edward P. Chen et al.
CARCINOGENESIS (2014)
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Yonit Lavin et al.
CELL (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Macrophage phenotypes in atherosclerosis
Sophie Colin et al.
IMMUNOLOGICAL REVIEWS (2014)
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Haihui Lu et al.
NATURE CELL BIOLOGY (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
Martin Oft
CANCER IMMUNOLOGY RESEARCH (2014)
Role of tumor assocaited macrophages in tumor angiogenesis and lymphangiogenesis
Vladimir Riabov et al.
FRONTIERS IN PHYSIOLOGY (2014)
Interactions between HLA-G and HLA-E in physiological and pathological conditions
Fabio Morandi et al.
FRONTIERS IN IMMUNOLOGY (2014)
Monocytes and macrophages: developmental pathways and tissue homeostasis
Florent Ginhoux et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator
Philip Vlaicu et al.
BMC CANCER (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
Felix Klug et al.
CANCER CELL (2013)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
Lei Zhao et al.
HEPATOLOGY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Subhra K. Biswas et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
Jian Yang et al.
STEM CELLS (2013)
Macrophages Good guys in colorectal cancer
Sofia Edin et al.
ONCOIMMUNOLOGY (2013)
Inflammation and Cancer: A Comparative View
Wallace B. Morrison
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Regulation of Macrophage Polarization and Wound Healing
Christopher J. Ferrante et al.
ADVANCES IN WOUND CARE (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Transition of tumor-associated macrophages from MHC class IIhi to MHC class IIlow mediates tumor progression in mice
Benfan Wang et al.
BMC IMMUNOLOGY (2011)
Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
Qing Chen et al.
CANCER CELL (2011)
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T. Pallotta et al.
NATURE IMMUNOLOGY (2011)
Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
Jinlin Liu et al.
PLOS ONE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis
Lin Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer
Akihiko Kawahara et al.
ONCOLOGY REPORTS (2010)
Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model
Seyed Javad Moghaddam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
A Recurrent Network Involving the Transcription Factors PU.1 and Gfi1 Orchestrates Innate and Adaptive Immune Cell Fates
Chauncey J. Spooner et al.
IMMUNITY (2009)
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro
M. F. Moreau et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
